Lillian Edith Thompson, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3860 Lombardy St, Hollywood, FL 33021 Phone: 954-985-8270 |
Samantha Ren Rivero, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3335 N University Dr Ste 5, Hollywood, FL 33024 Phone: 954-442-9422 |
Communcation Connections And Consulting Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1425 Arthur St Apt 208, Hollywood, FL 33020 Phone: 954-295-4623 |
Lourdes Barros, MS/CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3335 N University Dr Ste 5, Hollywood, FL 33024 Phone: 954-442-9150 |
Mrs. Venita Marie Litvack, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3335 N University Dr, Suite 5, Hollywood, FL 33024 Phone: 954-442-9422 Fax: 954-442-9150 |
Emily Megan Matthews, M.S., CF- SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Oakwood Blvd Ste 130, Hollywood, FL 33020 Phone: 954-925-3844 |
Ms. Vanessa Dolores Montoya, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4200 Hillcrest Dr Apt 110, Hollywood, FL 33021 Phone: 509-630-9575 |
Marisol Hernandez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Oakwood Blvd, Suite 130, Hollywood, FL 33020 Phone: 954-925-3844 Fax: 954-925-3845 |
Yenisleidys Cabanes Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5916 Mckinley St, Hollywood, FL 33021 Phone: 305-528-9970 |
Geraldine Darius Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Oakwood Blvd, Hollywood, FL 33020 Phone: 786-556-5074 |
Mrs. Paulina Ladowski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5451 Buchanan St, Hollywood, FL 33021 Phone: 786-619-5634 |
Anthony Bianco Iii Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3335 N University Dr Ste 5, Hollywood, FL 33024 Phone: 195-444-2942 |
Lillian Flowers Rogers, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Oakwood Blvd Ste 130, Hollywood, FL 33020 Phone: 954-925-3844 |
Alleyah Ingraham Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2736 Hollywood Blvd, Hollywood, FL 33020 Phone: 954-603-1881 |
Katzen Holistic Speech-language Pathology, Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 10539 Zurich St, Hollywood, FL 33026 Phone: 305-733-3739 |
Sara Sadler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3335 N University Dr Ste 5, Hollywood, FL 33024 Phone: 954-442-9422 Fax: 954-442-9150 |
Madison Moss, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5555 Hollywood Blvd Ste 201, Hollywood, FL 33021 Phone: 954-603-1881 |
Ms. Zulekha Shaikh, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2736 Hollywood Blvd, Hollywood, FL 33020 Phone: 954-603-1881 |
Brooke C Perez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Oakwood Blvd Ste 130, Hollywood, FL 33020 Phone: 954-925-3844 |
Christine Scott Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Oakwood Blvd, #130, Hollywood, FL 33020 Phone: 954-925-3844 |
News Archive
Women with osteoporosis - a skeletal disease that erodes bone density, weakens bone strength and increases the risk of fractures - might think taking it easy is the best way to prevent bone breaks.
States have taken a variety of trims, from stopping payments for circumcisions in Colorado to reducing payments for rehabilitation services in Kansas to increased co-payments in California.
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (NDA) for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
Melior Discovery, Inc. announced today the United States Patent and Trademark Office (USTPO) has awarded a Notice of Allowance for a broad patent application covering the Company's use of MLR-1023 for, among other things, the treatment of type II diabetes and obesity. The patent will cover use of MLR-1023 for the treatment of type II diabetes, obesity and metabolic syndrome, including its use in combination with other compounds and as a component in other drugs.
The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.
› Verified 3 days ago